152 related articles for article (PubMed ID: 21945679)
1. Facilitated intracellular delivery of peptide-guided nanoparticles in tumor tissues.
Kim JH; Bae SM; Na MH; Shin H; Yang YJ; Min KH; Choi KY; Kim K; Park RW; Kwon IC; Lee BH; Hoffman AS; Kim IS
J Control Release; 2012 Feb; 157(3):493-9. PubMed ID: 21945679
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
3. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
4. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
[TBL] [Abstract][Full Text] [Related]
5. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
6. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
Hwang HY; Kim IS; Kwon IC; Kim YH
J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
[TBL] [Abstract][Full Text] [Related]
7. Targeted paclitaxel nanoparticles modified with follicle-stimulating hormone β 81-95 peptide show effective antitumor activity against ovarian carcinoma.
Zhang X; Chen J; Kang Y; Hong S; Zheng Y; Sun H; Xu C
Int J Pharm; 2013 Sep; 453(2):498-505. PubMed ID: 23811008
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite.
Yuk SH; Oh KS; Cho SH; Kim SY; Oh S; Lee JH; Kim K; Kwon IC
Mol Pharm; 2012 Feb; 9(2):230-6. PubMed ID: 22149139
[TBL] [Abstract][Full Text] [Related]
9. Effect of the stability and deformability of self-assembled glycol chitosan nanoparticles on tumor-targeting efficiency.
Na JH; Lee SY; Lee S; Koo H; Min KH; Jeong SY; Yuk SH; Kim K; Kwon IC
J Control Release; 2012 Oct; 163(1):2-9. PubMed ID: 22846988
[TBL] [Abstract][Full Text] [Related]
10. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
[TBL] [Abstract][Full Text] [Related]
11. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.
Nam HY; Kwon SM; Chung H; Lee SY; Kwon SH; Jeon H; Kim Y; Park JH; Kim J; Her S; Oh YK; Kwon IC; Kim K; Jeong SY
J Control Release; 2009 May; 135(3):259-67. PubMed ID: 19331853
[TBL] [Abstract][Full Text] [Related]
12. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
13. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.
Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC
J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.
Kim JH; Kim YS; Park K; Kang E; Lee S; Nam HY; Kim K; Park JH; Chi DY; Park RW; Kim IS; Choi K; Chan Kwon I
Biomaterials; 2008 Apr; 29(12):1920-30. PubMed ID: 18289669
[TBL] [Abstract][Full Text] [Related]
15. Blood-pool multifunctional nanoparticles formed by temperature-induced phase transition for cancer-targeting therapy and molecular imaging.
Oh KS; Lee S; Na JH; Kim JY; Kim DE; Kim K; Kwon IC; Yuk SH; Jeong SY
Int J Pharm; 2012 Nov; 437(1-2):192-202. PubMed ID: 22944301
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional drug delivery system for targeting tumor and its acidic microenvironment.
Shen M; Huang Y; Han L; Qin J; Fang X; Wang J; Yang VC
J Control Release; 2012 Aug; 161(3):884-92. PubMed ID: 22587941
[TBL] [Abstract][Full Text] [Related]
17. An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery.
Li S; Su Z; Sun M; Xiao Y; Cao F; Huang A; Li H; Ping Q; Zhang C
Int J Pharm; 2012 Oct; 436(1-2):248-57. PubMed ID: 22732672
[TBL] [Abstract][Full Text] [Related]
18. Shell-crosslinked hybrid nanoparticles for direct cytosolic delivery for tumor therapy.
He W; Jin Z; Lv Y; Cao H; Yao J; Zhou J; Yin L
Int J Pharm; 2015 Jan; 478(2):762-72. PubMed ID: 25529435
[TBL] [Abstract][Full Text] [Related]
19. Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models.
Na JH; Koo H; Lee S; Min KH; Park K; Yoo H; Lee SH; Park JH; Kwon IC; Jeong SY; Kim K
Biomaterials; 2011 Aug; 32(22):5252-61. PubMed ID: 21513975
[TBL] [Abstract][Full Text] [Related]
20. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC
J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
